UK Anti-Doping v Carl Hone


UK Anti-Doping v Carl Hone

A decision in the case of UK Anti-Doping (UKAD) v Carl Hone has been published by the National Anti-Doping Panel (NADP).

On 06 February 2020, Mr Carl Hone, a rugby union player in Wales registered with Llanhilleth RFC, provided urine Sample Out-of-Competition. Sample analysis returned an Adverse Analytical Finding (“AAF”) for Boldenone.  

Mr Hone was subsequently charged on 12 October 2020 with a breach of ADR Article 2.1 for the Presence of a Prohibited Substance or its Metabolites or Markers in his Sample. Mr Hone admitted the Anti-Doping Rule Violation on 02 November 2020. 

The NADP Tribunal, consisting of Robert Englehart QC (Chair), Professor Peter Sever and Carole Billington-Wood established that Mr Hone had committed an Anti-Doping Rule Violation contrary to ADR Art. 2.1, and therefore imposed a period of Ineligibility of 4 years, commencing on 06 February 2020 until midnight on 05 February 2024.

A copy of the full decision can be accessed via the related documents tab on the right-hand side.

The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of UK Anti-Doping who is responsible for investigating, charging, and prosecuting cases before the NADP.

You may also like

View All

Pinned Article

Sport Resolutions Annual Conference 2025: Tickets Now On Sale!

We are thrilled to announce that tickets for our 10th Annual Conference are now available! 

Read More

WADA Executive Committee establishes Working Group on Contaminations

The World Anti-Doping Agency’s Executive Committee has established a Working Group on contaminations to strengthen the global anti-doping system 

Read More

Cricket Regulator v Keith Barker

A decision in the case of the Cricket Regulator (CR) against Keith Barker has been issued by the National Anti-Doping Panel (NADP).

Read More

Newsletter Signup

Please enter your email address below: